Literature DB >> 16189805

A multiple testing procedure to associate gene expression levels with survival.

Sin-Ho Jung1, Kouros Owzar, Stephen L George.   

Abstract

In many microarray studies the primary objective is to identify, from a large panel of genes, those which are prognostic markers of a censored survival endpoint such as time to disease recurrence or death. Often, these genes are considered prognostic in that their respective expressions are associated with the survival endpoint of interest. To assess this association requires specifying an appropriate measure of association, a suitable test statistic and, as the number of genes is large, proper handling of multiplicity issues. In this paper, we will address these issues by utilizing a general correlation measure, a non-parametric test statistic, and control of the family-wise error rate by employing permutation resampling. Comprehensive simulation studies are conducted to investigate the statistical properties of the proposed procedure. The proposed method is applied to a recently published data set on patients with lung cancer. 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2005        PMID: 16189805     DOI: 10.1002/sim.2179

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  16 in total

1.  Detection of minimal residual disease following induction immunochemotherapy predicts progression free survival in mantle cell lymphoma: final results of CALGB 59909.

Authors:  Hongtao Liu; Jeffrey L Johnson; Greg Koval; Greg Malnassy; Dorie Sher; Lloyd E Damon; Eric D Hsi; Donna Marie Bucci; Charles A Linker; Bruce D Cheson; Wendy Stock
Journal:  Haematologica       Date:  2011-11-18       Impact factor: 9.941

2.  RRM1 and RRM2 pharmacogenetics: association with phenotypes in HapMap cell lines and acute myeloid leukemia patients.

Authors:  Xueyuan Cao; Amit K Mitra; Stanley Pounds; Kristine R Crews; Varsha Gandhi; William Plunkett; M Eileen Dolan; Christine Hartford; Susana Raimondi; Dario Campana; James Downing; Jeffrey E Rubnitz; Raul C Ribeiro; Jatinder K Lamba
Journal:  Pharmacogenomics       Date:  2013-09       Impact factor: 2.533

3.  PROMISE: a tool to identify genomic features with a specific biologically interesting pattern of associations with multiple endpoint variables.

Authors:  Stan Pounds; Cheng Cheng; Xueyuan Cao; Kristine R Crews; William Plunkett; Varsha Gandhi; Jeffrey Rubnitz; Raul C Ribeiro; James R Downing; Jatinder Lamba
Journal:  Bioinformatics       Date:  2009-06-15       Impact factor: 6.937

Review 4.  Statistical considerations for analysis of microarray experiments.

Authors:  Kouros Owzar; William T Barry; Sin-Ho Jung
Journal:  Clin Transl Sci       Date:  2011-11-07       Impact factor: 4.689

5.  Genetic variants in cytosolic 5'-nucleotidase II are associated with its expression and cytarabine sensitivity in HapMap cell lines and in patients with acute myeloid leukemia.

Authors:  Amit K Mitra; Kristine R Crews; Stanley Pounds; Xueyuan Cao; Tanya Feldberg; Yogita Ghodke; Varsha Gandhi; William Plunkett; M Eileen Dolan; Christine Hartford; Susana Raimondi; Dario Campana; James Downing; Jeffrey E Rubnitz; Raul C Ribeiro; Jatinder K Lamba
Journal:  J Pharmacol Exp Ther       Date:  2011-06-28       Impact factor: 4.030

6.  25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance).

Authors:  Katherine Van Loon; Kouros Owzar; Chen Jiang; Hedy L Kindler; Mary F Mulcahy; Donna Niedzwiecki; Eileen M O'Reilly; Charles Fuchs; Federico Innocenti; Alan P Venook
Journal:  J Natl Cancer Inst       Date:  2014-08-06       Impact factor: 13.506

Review 7.  Statistical challenges in preprocessing in microarray experiments in cancer.

Authors:  Kouros Owzar; William T Barry; Sin-Ho Jung; Insuk Sohn; Stephen L George
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

8.  permGPU: Using graphics processing units in RNA microarray association studies.

Authors:  Ivo D Shterev; Sin-Ho Jung; Stephen L George; Kouros Owzar
Journal:  BMC Bioinformatics       Date:  2010-06-16       Impact factor: 3.169

9.  Clinical significance of in vivo cytarabine-induced gene expression signature in AML.

Authors:  Jatinder K Lamba; Stanley Pounds; Xueyuan Cao; Kristine R Crews; Christopher R Cogle; Neha Bhise; Susana C Raimondi; James R Downing; Sharyn D Baker; Raul C Ribeiro; Jeffrey E Rubnitz
Journal:  Leuk Lymphoma       Date:  2015-10-16

10.  Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study.

Authors:  Eric D Hsi; Sin-Ho Jung; Raymond Lai; Jeffrey L Johnson; James R Cook; Dan Jones; Sven Devos; Bruce D Cheson; Lloyd E Damon; Jonathan Said
Journal:  Leuk Lymphoma       Date:  2008-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.